24
Views
0
CrossRef citations to date
0
Altmetric
Review

Lost in translation: five grand challenges for proteomic biomarker discovery

, PhD, , MD & , PhD
Pages 325-336 | Published online: 09 Nov 2007

Bibliography

  • HU P, BADER G, WIGLE DA, EMILI A: Computational prediction of cancer-gene function. Nat. Rev. Cancer (2007) 7(1):23-34.
  • KISLINGER T, COX B, KANNAN A et al.: Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell (2006) 125(1):173-186.
  • SINTCHENKO V, IREDELL JR, GILBERT GL: Pathogen profiling for disease management and surveillance. Nat. Rev. Microbiol. (2007) 5(6):464-470.
  • HIETER P, BOGUSKI M: Functional genomics: it's all how you read it. Science (1997) 278(5338):601-602.
  • GRAMOLINI AO, EMILI A: Uncovering early markers of cardiac disease by proteomics: avoiding (heart) failure! Expert Rev. Proteomics (2005) 2(5):631-634.
  • ARAB S, GRAMOLINI AO, PING P et al.: Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J. Am. Coll. Cardiol. (2006) 48(9):1733-1741.
  • HARTWELL L, MANKOFF D, PAULOVICH A, RAMSEY S, SWISHER E: Cancer biomarkers: a systems approach. Nat. Biotechnol. (2006) 24(8):905-908.
  • KAYE DM, KRUM H: Drug discovery for heart failure: a new era or the end of the pipeline? Nat. Rev. Drug Discov. (2007) 6(2):127-139.
  • DIAMANDIS EP: Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J. Natl. Cancer Inst. (2004) 96(5):353-356.
  • DIAMANDIS EP: Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol. Cell Proteomics (2004) 3(4):367-378.
  • JOHANSEN H, STRAUSS B, ARNOLD JM, MOE G, LIU P: On the rise: the current and projected future burden of congestive heart failure hospitalization in Canada. Can. J. Cardiol. (2003) 19(4):430-435.
  • MANTINI D, PETRUCCI F, PIERAGOSTINO D et al.: LIMPIC: a computational method for the separation of protein MALDI-TOF-MS signals from noise. BMC Bioinform. (2007) 8:101.
  • KAPP EA, SCHUTZ F, CONNOLLY LM et al.: An evaluation, comparison, and accurate benchmarking of several publicly available MS/MS search algorithms: sensitivity and specificity analysis. Proteomics (2005) 5(13):3475-3490.
  • LISTGARTEN J, EMILI A: Statistical and computational methods for comparative proteomic profiling using liquid chromatography-tandem mass spectrometry. Mol. Cell Proteomics (2005) 4(4):419-434.
  • GRAMOLINI AO, TRIVIERI MG, OUDIT GY et al.: Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation. Proc. Natl. Acad. Sci. USA (2006) 103(7):2446-2451.
  • ANDERSON NL, ANDERSON NG: The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteomics (2002) 1(11):845-867.
  • ZEREFOS P, PRADOS J, KOSSIDA S, KALOUSIS A, VLAHOU A: Sample preparation and bioinformatics in MALDI profiling of urinary proteins. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2007) 853(1-2):20-30.
  • NICHOLAS B, SKIPP P, MOULD R et al.: Shotgun proteomic analysis of human-induced sputum. Proteomics (2006) 6(15):4390-4401.
  • HU S, LOO JA, WONG DT: Human saliva proteome analysis. Ann. NY Acad. Sci. (2007) 1098:323-329.
  • SAUTER ER, SHAN S, HEWETT JE, SPECKMAN P, DU BOIS GC: Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS. Int. J. Cancer (2005) 114(5):791-796.
  • TSAI PS, EVANS JE, GREEN KM et al.: Proteomic analysis of human meibomian gland secretions. Br. J. Ophthalmol. (2006) 90(3):372-377.
  • LEE KH, RELKIN NR: Reply: cerebrospinal fluid proteomics for biomarkers of Alzheimer's disease. Ann. Neurol. (2007) 61(5):497-498.
  • KHARITONOV SA, BARNES PJ: Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. (2004) 1(3):191-199.
  • HU S, LOO JA, WONG DT: Human body fluid proteome analysis. Proteomics (2006) 6(23):6326-6353.
  • ANDERSON L, HUNTER CL: Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell Proteomics (2006) 5(4):573-588.
  • DIAMANDIS EP: Oncopeptidomics: a useful approach for cancer diagnosis? Clin. Chem. (2007) 53(6):1004-1006.
  • RIFAI N, GILLETTE MA, CARR SA: Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. (2006) 24(8):971-983.
  • LARSSON TP, MURRAY CG, HILL T, FREDRIKSSON R, SCHIOTH HB: Comparison of the current RefSeq, Ensembl and EST databases for counting genes and gene discovery. FEBS Lett. (2005) 579(3):690-698.
  • BARELLI S, CRETTAZ D, THADIKKARAN L, RUBIN O, TISSOT JD: Plasma/serum proteomics: pre-analytical issues. Expert Rev. Proteomics (2007) 4(3):363-370.
  • ANDERSON NL: The roles of multiple proteomic platforms in a pipeline for new diagnostics. Mol. Cell Proteomics (2005) 4(10):1441-1444.
  • SEMMES OJ, MALIK G, WARD M: Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer. J. Cell Biochem. (2006) 98(3):496-503.
  • KISLINGER T, RAHMAN K, RADULOVIC D et al.: PRISM, a generic large scale proteomic investigation strategy for mammals. Mol. Cell Proteomics (2003) 2(2):96-106.
  • RESING KA, MEYER-ARENDT K, MENDOZA AM et al.: Improving reproducibility and sensitivity in identifying human proteins by shotgun proteomics. Anal. Chem. (2004) 76(13):3556-3568.
  • TAM SW, PIRRO J, HINERFELD D: Depletion and fractionation technologies in plasma proteomic analysis. Expert Rev. Proteomics (2004) 1(4):411-420.
  • ECHAN LA, TANG HY, ALI-KHAN N, LEE K, SPEICHER DW: Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics (2005) 5(13):3292-3303.
  • WISSING J, JANSCH L, NIMTZ M et al.: Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry. Mol. Cell Proteomics (2007) 6(3):537-547.
  • COX B, EMILI A: Tissue subcellular fractionation and protein extraction for use in mass-spectrometry-based proteomics. Nat. Protoc. (2006) 1(4):1872-1878.
  • BLONDER J, CHAN KC, ISSAQ HJ, VEENSTRA TD: Identification of membrane proteins from mammalian cell/tissue using methanol-facilitated solubilization and tryptic digestion coupled with 2D-LC-MS/MS. Nat. Protoc. (2006) 1(6):2784-2790.
  • TEMPORINI C, PERANI E, CALLERI E et al.: Pronase-immobilized enzyme reactor: an approach for automation in glycoprotein analysis by LC/LC-ESI/MSn. Anal. Chem. (2007) 79(1):355-363.
  • HAVUGIMANA PC, WONG P, EMILI A: Improved proteomic discovery by sample pre-fractionation using dual-column ion-exchange high performance liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2007) 847(1):54-61.
  • QIAN WJ, GOSHE MB, CAMP DG II et al.: Phosphoprotein isotope-coded solid-phase tag approach for enrichment and quantitative analysis of phosphopeptides from complex mixtures. Anal. Chem. (2003) 75(20):5441-5450.
  • GARCIA BA, SHABANOWITZ J, HUNT DF: Analysis of protein phosphorylation by mass spectrometry. Methods (2005) 35(3):256-264.
  • HAVILIO M, WOOL A: Large-scale unrestricted identification of post-translation modifications using tandem mass spectrometry. Anal. Chem. (2007) 79(4):1362-1368.
  • CHO WC: Contribution of oncoproteomics to cancer biomarker discovery. Mol. Cancer (2007) 6:25.
  • ANDERSON L: Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J. Physiol. (2005) 563(Part 1):23-60.
  • AHN NG, SHABB JB, OLD WM, RESING KA: Achieving in-depth proteomics profiling by mass spectrometry. ACS Chem. Biol. (2007) 2(1):39-52.
  • DOMON B, AEBERSOLD R: Mass spectrometry and protein analysis. Science (2006) 312(5771):212-217.
  • KISLINGER T, GRAMOLINI AO, MACLENNAN DH, EMILI A: Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue. J. Am. Soc. Mass Spectrom. (2005) 16(8):1207-1220.
  • LIU C, ZHANG X: Multidimensional capillary array liquid chromatography and matrix-assisted laser desorption/ionization tandem mass spectrometry for high-throughput proteomic analysis. J. Chromatogr. A (2007) 1139(2):191-198.
  • MANN M: Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell Biol. (2006) 7(12):952-958.
  • RADULOVIC D, JELVEH S, RYU S et al.: Informatics platform for global proteomic profiling and biomarker discovery using liquid chromatography-tandem mass spectrometry. Mol. Cell Proteomics (2004) 3(10):984-997.
  • VITZTHUM F, BEHRENS F, ANDERSON NL, SHAW JH: Proteomics: from basic research to diagnostic application. A review of requirements and needs. J. Proteome Res. (2005) 4(4):1086-1097.
  • RAMACHANDRAN N, HAINSWORTH E, DEMIRKAN G, LABAER J: On-chip protein synthesis for making microarrays. Methods Mol. Biol. (2006) 328:1-14.
  • HE M, TAUSSIG MJ: Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method). Nucleic Acids Res. (2001) 29(15):E73-E73.
  • ANGENENDT P, WILDE J, KIJANKA G et al.: Seeing better through a MIST: evaluation of monoclonal recombinant antibody fragments on microarrays. Anal. Chem. (2004) 76(10):2916-2921.
  • ZHANG J, XU X, SHEN H, ZHANG X: Analysis of nuclear proteome in C57 mouse liver tissue by a nano-flow 2-D-LC-ESI-MS/MS approach. J. Sep. Sci. (2006) 29(17):2635-2646.
  • BLAUSTEIN M, PELISCH F, SREBROW A: Signals, pathways and splicing regulation. Int. J. Biochem. Cell Biol. (2007) 39(11):2031-2048.
  • ITO K: Impact of post-translational modifications of proteins on the inflammatory process. Biochem. Soc. Trans. (2007) 35(Part 2):281-283.
  • ZOLNIEROWICZ S, BOLLEN M: Protein phosphorylation and protein phosphatases. De Panne, Belgium, 19 – 24 September, 1999. EMBO J. (2000) 19(4):483-488.
  • WALSH G, JEFFERIS R: Post-translational modifications in the context of therapeutic proteins. Nat. Biotechnol. (2006) 24(10):1241-1252.
  • TSENG HC, OVAA H, WEI NJ, PLOEGH H, TSAI LH: Phosphoproteomic analysis with a solid-phase capture-release-tag approach. Chem. Biol. (2005) 12(7):769-777.
  • HUANG J, QI R, QUACKENBUSH J et al.: Effects of ischemia on gene expression. J. Surg. Res. (2001) 99(2):222-227.
  • CRAVEN RA, BANKS RE: Laser capture microdissection and proteomics: possibilities and limitation. Proteomics (2001) 1(10):1200-1204.
  • QI L, DANIELSON ND: Quantitative determination of pharmaceuticals using nano-electrospray ionization mass spectrometry after reversed phase mini-solid phase extraction. J. Pharm. Biomed. Anal. (2005) 37(2):225-230.
  • CHAURASIA G, HERZEL H, WANKER EE, FUTSCHIK ME: Systematic functional assessment of human protein–protein interaction maps. Genome Inform. (2006) 17(1):36-45.
  • COLUCCI WS, ELKAYAM U, HORTON DP et al.: Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide study group. N. Engl. J. Med. (2000) 343(4):246-253.
  • CORTI R, BURNETT JC Jr, ROULEAU JL, RUSCHITZKA F, LUSCHER TF: Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? Circulation (2001) 104(15):1856-1862.
  • DORN GW II: The fuzzy logic of physiological cardiac hypertrophy. Hypertension (2007) 49(5):962-970.
  • PENPARGKUL S, SCHEUER J: The effect of physical training upon the mechanical and metabolic performance of the rat heart. J. Clin. Invest. (1970) 49(10):1859-1868.
  • SCHEUER J, MALHOTRA A, HIRSCH C, CAPASSO J, SCHAIBLE TF: Physiologic cardiac hypertrophy corrects contractile protein abnormalities associated with pathologic hypertrophy in rats. J. Clin. Invest. (1982) 70(6):1300-1305.
  • FREY N, OLSON EN: Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. (2003) 65:45-79.
  • RAJABI M, KASSIOTIS C, RAZEGHI P, TAEGTMEYER H: Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail. Rev. (2007).
  • GIORDANO FJ, GERBER HP, WILLIAMS SP et al.: A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc. Natl. Acad. Sci. USA (2001) 98(10):5780-5785.
  • SANO M, MINAMINO T, TOKO H et al.: p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature (2007) 446(7134):444-448.
  • KITANO H: Biological robustness. Nat. Rev. Genet. (2004) 5(11):826-837.
  • PAN Y, KISLINGER T, GRAMOLINI AO et al.: Identification of biochemical adaptations in hyper- or hypocontractile hearts from phospholamban mutant mice by expression proteomics. Proc. Natl. Acad. Sci. USA (2004) 101(8):2241-2246.
  • FUSE K, CHAN G, LIU Y et al.: Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation (2005) 112(15):2276-2285.
  • ALIZADEH AA, ROSS DT, PEROU CM, VAN DE RIJN M: Towards a novel classification of human malignancies based on gene expression patterns. J. Pathol. (2001) 195(1):41-52.
  • GLAS AM, FLOORE A, DELAHAYE LJ et al.: Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics (2006) 7:278.
  • BACKS J, SONG K, BEZPROZVANNAYA S, CHANG S, OLSON EN: CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J. Clin. Invest. (2006) 116(7):1853-1864.
  • NALDI M, ANDRISANO V, FIORI J et al.: Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry. J. Chromatogr. A (2006) 1129(1):73-81.
  • COX B, KISLINGER T, EMILI A: Integrating gene and protein expression data: pattern analysis and profile mining. Methods (2005) 35(3):303-314.
  • CHANG TC, MENDELL JT: The roles of microRNAs in vertebrate physiology and human disease. Annu. Rev. Genomics Hum. Genet. (2007).
  • BUSHATI N, COHEN SM: microRNA functions. Annu. Rev. Cell Dev. Biol. (2007) 23:175-205.
  • VAN ROOIJ E, SUTHERLAND LB, QI X et al.: Control of stress-dependent cardiac growth and gene expression by a microRNA. Science (2007) 316(5824):575-579.
  • CHIEN KR: Molecular medicine: microRNAs and the tell-tale heart. Nature (2007) 447(7143):389-390.
  • MANN DL: MicroRNAs and the failing heart. N. Engl. J. Med. (2007) 356(25):2644-2645.
  • PONJAVIC J, PONTING CP, LUNTER G: Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res. (2007) 17(5):556-565.
  • POTTER JD: At the interfaces of epidemiology, genetics and genomics. Nat. Rev. Genet. (2001) 2(2):142-147.
  • GIBBONS GH, LIEW CC, GOODARZI MO et al.: Genetic markers: progress and potential for cardiovascular disease. Circulation (2004) 109(25 Suppl. 1):IV47-IV58.
  • SONG Y, STAMPFER MJ, LIU S: Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann. Intern. Med. (2004) 141(2):137-147.
  • SARZANI R, SALVI F, DESSI-FULGHERI P et al.: Aldosterone synthase alleles and cardiovascular phenotype in young adults. J. Hum. Hypertens. (2003) 17(12):859-864.
  • SHIN J, JOHNSON JA: Pharmacogenetics of β-blockers. Pharmacotherapy (2007) 27(6):874-887.
  • FU Q, VAN EYK JE: Proteomics and heart disease: identifying biomarkers of clinical utility. Expert Rev. Proteomics (2006) 3(2):237-249.
  • CHU G, HAGHIGHI K, KRANIAS EG: From mouse to man: understanding heart failure through genetically altered mouse models. J. Card. Fail. (2002) 8(6 Suppl.):S432-S449.
  • KOOMEN JM, WILSON CR, GUTHRIE P et al.: Proteome analysis of isolated perfused organ effluent as a novel model for protein biomarker discovery. J. Proteome Res. (2006) 5(1):177-182.
  • SCHMITT JP, KAMISAGO M, ASAHI M et al.: Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science (2003) 299(5611):1410-1413.
  • LIESCHKE GJ, CURRIE PD: Animal models of human disease: zebrafish swim into view. Nat. Rev. Genet. (2007) 8(5):353-367.
  • TAN HL: Sodium channel variants in heart disease: expanding horizons. J. Cardiovasc. Electrophysiol. (2006) 17(Suppl. 1):S151-S157.
  • CHAPMAN C, MURRAY A, CHAKRABARTI J et al.: Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann. Oncol. (2007) 18(5):868-873.
  • YE B, GAGNON A, MOK SC: Recent technical strategies to identify diagnostic biomarkers for ovarian cancer. Expert Rev. Proteomics (2007) 4(1):121-131.
  • BURKE MA, COTTS WG: Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Fail. Rev. (2007) 12(1):23-36.
  • WANG W, DAVIS CS, SOONG SJ: Comparison of predictive values of two diagnostic tests from the same sample of subjects using weighted least squares. Stat. Med. (2006) 25(13):2215-2229.

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.